中外製薬の株価時系列
| 日付 | 始値 | 高値 | 安値 | 終値 | 前日比 | 騰落率 | 出来高 |
|---|---|---|---|---|---|---|---|
| 2025/06/02 | 7,550 | 7,740 | 7,525 | 7,731 | +148 | +2% | 1,657,000 |
| 2025/05/30 | 7,483 | 7,627 | 7,463 | 7,583 | -17 | -0.2% | 4,790,600 |
| 2025/05/29 | 7,617 | 7,632 | 7,527 | 7,600 | +105 | +1.4% | 1,280,700 |
| 2025/05/28 | 7,598 | 7,625 | 7,460 | 7,495 | -107 | -1.4% | 1,509,500 |
| 2025/05/27 | 7,520 | 7,644 | 7,520 | 7,602 | +40 | +0.5% | 1,153,300 |
| 2025/05/26 | 7,508 | 7,570 | 7,468 | 7,562 | +2 | ±0% | 1,191,000 |
| 2025/05/23 | 7,620 | 7,639 | 7,510 | 7,560 | +44 | +0.6% | 1,616,000 |
| 2025/05/22 | 7,383 | 7,544 | 7,379 | 7,516 | +146 | +2% | 2,071,000 |
| 2025/05/21 | 7,553 | 7,565 | 7,370 | 7,370 | -197 | -2.6% | 2,250,000 |
| 2025/05/20 | 7,806 | 7,825 | 7,502 | 7,567 | -89 | -1.2% | 2,202,200 |
| 2025/05/19 | 7,526 | 7,670 | 7,412 | 7,656 | +129 | +1.7% | 1,625,600 |
| 2025/05/16 | 7,582 | 7,600 | 7,403 | 7,527 | +12 | +0.2% | 1,748,700 |
| 2025/05/15 | 7,400 | 7,547 | 7,398 | 7,515 | +15 | +0.2% | 1,696,600 |
| 2025/05/14 | 7,360 | 7,500 | 7,333 | 7,500 | -10 | -0.1% | 2,263,800 |
| 2025/05/13 | 7,645 | 7,746 | 7,502 | 7,510 | +206 | +2.8% | 3,657,900 |
| 2025/05/12 | 7,760 | 7,810 | 7,304 | 7,304 | -915 | -11.1% | 5,086,500 |
| 2025/05/09 | 8,335 | 8,372 | 8,137 | 8,219 | -93 | -1.1% | 2,983,100 |
| 2025/05/08 | 8,606 | 8,614 | 8,308 | 8,312 | -158 | -1.9% | 1,886,700 |
| 2025/05/07 | 8,619 | 8,619 | 8,438 | 8,470 | -150 | -1.7% | 3,600,500 |
| 2025/05/02 | 8,456 | 8,655 | 8,341 | 8,620 | +181 | +2.1% | 4,157,300 |
| 2025/05/01 | 8,325 | 8,481 | 8,258 | 8,439 | +220 | +2.7% | 1,695,800 |
| 2025/04/30 | 8,103 | 8,274 | 8,054 | 8,219 | +201 | +2.5% | 3,470,600 |
| 2025/04/28 | 8,252 | 8,269 | 7,972 | 8,018 | -256 | -3.1% | 2,641,200 |
| 2025/04/25 | 8,539 | 8,540 | 8,181 | 8,274 | +23 | +0.3% | 3,484,900 |
| 2025/04/24 | 8,100 | 8,395 | 8,069 | 8,251 | +57 | +0.7% | 2,986,200 |
| 2025/04/23 | 8,227 | 8,330 | 8,114 | 8,194 | -119 | -1.4% | 3,501,200 |
| 2025/04/22 | 8,351 | 8,367 | 8,222 | 8,313 | -107 | -1.3% | 2,705,600 |
| 2025/04/21 | 8,292 | 8,459 | 8,210 | 8,420 | +92 | +1.1% | 3,276,400 |
| 2025/04/18 | 8,065 | 8,427 | 7,897 | 8,328 | +1,243 | +17.5% | 10,232,300 |
| 2025/04/17 | 6,826 | 7,085 | 6,804 | 7,085 | +332 | +4.9% | 2,687,900 |
| 2025/04/16 | 6,694 | 6,753 | 6,639 | 6,753 | +115 | +1.7% | 1,665,700 |
| 2025/04/15 | 6,674 | 6,752 | 6,605 | 6,638 | +36 | +0.5% | 1,393,200 |
| 2025/04/14 | 6,380 | 6,697 | 6,360 | 6,602 | +316 | +5% | 2,393,000 |
| 2025/04/11 | 6,384 | 6,451 | 6,232 | 6,286 | -432 | -6.4% | 3,678,900 |
| 2025/04/10 | 6,759 | 6,804 | 6,631 | 6,718 | +359 | +5.6% | 2,542,800 |
| 2025/04/09 | 6,450 | 6,508 | 6,291 | 6,359 | -183 | -2.8% | 2,551,100 |
| 2025/04/08 | 6,585 | 6,627 | 6,425 | 6,542 | +150 | +2.3% | 2,640,300 |
| 2025/04/07 | 6,554 | 6,640 | 6,287 | 6,392 | -262 | -3.9% | 3,343,100 |
| 2025/04/04 | 6,631 | 6,930 | 6,569 | 6,654 | +26 | +0.4% | 3,146,000 |
| 2025/04/03 | 6,385 | 6,679 | 6,380 | 6,628 | +43 | +0.7% | 2,713,500 |
| 2025/04/02 | 6,714 | 6,758 | 6,546 | 6,585 | -203 | -3% | 1,720,100 |
| 2025/04/01 | 6,816 | 6,889 | 6,752 | 6,788 | -11 | -0.2% | 1,574,700 |
| 2025/03/31 | 6,812 | 6,866 | 6,746 | 6,799 | -243 | -3.5% | 2,669,900 |
| 2025/03/28 | 7,003 | 7,059 | 6,945 | 7,042 | +3 | ±0% | 1,856,100 |
| 2025/03/27 | 7,006 | 7,137 | 7,006 | 7,039 | -52 | -0.7% | 2,072,900 |
| 2025/03/26 | 7,046 | 7,183 | 7,021 | 7,091 | +55 | +0.8% | 2,416,900 |
| 2025/03/25 | 7,048 | 7,085 | 6,957 | 7,036 | +115 | +1.7% | 1,494,600 |
| 2025/03/24 | 7,007 | 7,014 | 6,896 | 6,921 | +45 | +0.7% | 1,460,200 |
| 2025/03/21 | 6,752 | 6,967 | 6,752 | 6,876 | +140 | +2.1% | 3,373,300 |
| 2025/03/19 | 6,820 | 6,860 | 6,731 | 6,736 | -93 | -1.4% | 2,303,900 |
1～
50
件表示中 / 3711件
類似銘柄と比較する
現在ご覧いただいている「中外薬」と類似性の高い銘柄をピックアップ。投資家が注目しているデータで比較できるようになっています。銘柄選びの参考情報としてご活用ください。
| 銘柄名 | 最低購入代金 | 売上高 成長率 |
経常 増益率 |
配当 利回り |
PER | PBR | 直近のチャート | 特色 |
|---|---|---|---|---|---|---|---|---|
| 中外薬 | 753,000円 | +1.7% | +5.0% | 3.32% | 30.22倍 | 6.52倍 |
|
ロシュ傘下で成長続ける異色の医薬品大手。抗体・バイオで先行、抗がん剤、骨・関節領域に強い |
| 第一三共 | 372,600円 | +6.0% | +4.0% | 2.09% | 23.13倍 | 4.28倍 |
|
国内製薬大手。循環器と感染症薬強い。英アストラゼネカ社と提携し、がん領域の開拓中 |
| 武 田 | 428,200円 | -1.1% | +75.3% | 4.67% | 29.33倍 | 0.96倍 |
|
国内製薬首位。がん、中枢神経、消化器、希少疾患等に重点。巨額買収で世界売上上位１０強入り |
| 大塚ＨＤ | 698,700円 | +2.2% | +10.2% | 1.72% | 13.42倍 | 1.35倍 |
|
国内製薬大手で抗精神病薬が主力。ポカリスエットなど機能性食品も拡大。世界９０カ所に工場 |
| アステラス薬 | 142,600円 | +0.9% | +380.2% | 5.47% | 19.64倍 | 1.69倍 |
|
医薬品国内２位。開発技術起点の研究開発体制。前立腺がん薬が柱。遺伝子・細胞治療技術育成 |
市場注目の銘柄
チャート関連のコラム
